# FDA Inspection 765473 - Huashu Pharmaceutical Corporation - January 12, 2012

Source: https://www.keypedia.com/records/fda_inspections/huashu-pharmaceutical-corporation/e6a5a9a2-f4de-47eb-9782-7c6466697a5c
Source feed: FDA_Inspections

> FDA Inspection 765473 for Huashu Pharmaceutical Corporation on January 12, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 765473
- Company Name: Huashu Pharmaceutical Corporation
- Inspection Date: 2012-01-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 905343 - 2014-11-06](https://www.keypedia.com/records/fda_inspections/huashu-pharmaceutical-corporation/58d10010-56dd-4450-8264-cc195c524c7a)
- [FDA Inspection 765473 - 2012-01-12](https://www.keypedia.com/records/fda_inspections/huashu-pharmaceutical-corporation/66dc9110-16df-4b6f-b80a-24319e0c52cd)
- [FDA Inspection 572449 - 2009-02-13](https://www.keypedia.com/records/fda_inspections/huashu-pharmaceutical-corporation/6bc168e3-6c63-4a78-840e-662528486db5)

Company: https://www.keypedia.com/companies/huashu-pharmaceutical-corporation/872f0c58-3db7-466e-ba14-8461ef4518e9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c